Posts Tagged ‘Vaccines’
-
Tuesday, November 8th, 2011 at 00:37 | Comments Off
A.M. Vitals: Human Stem Cells Ease Parkinson’s Symptoms in RodentsCategories: Wall Street Journal
Human Cells, Rodent Brains: Research published in Nature describes how scientists treated Parkinson’s disease in mice and rats by converting human embryonic stem cells into nerve cells that released the neurotransmitter dopamine, then transplanting the cells into the rodents’ brains, the WSJ reports. Further animal studies are necessary before the technique could be tested in humans, the paper says.
MRSA and the Flu: Research published in Pediatrics finds infection by MRSA increased the chances that a previously healthy ..read more
-
Thursday, September 22nd, 2011 at 04:01 | Comments Off
Survey: People Have Big Plans For Flu ShotsCategories: Wall Street Journal
Nearly two in three people plan to get a flu shot this year and more health-care pros are recommending their patients get them, according to a National Foundation for Infectious Diseases survey released on Wednesday.
At a news conference in Washington D.C., public health officials and other medical experts provided coverage estimates for the seasonal flu vaccines this upcoming year and a snapshot of how many were inoculated last season.
The Centers for Disease Control and Prevention now recommends everyone above the ..read more
-
Thursday, September 22nd, 2011 at 03:44 | Comments Off
Health Law Means Fewer Young Adults Go Without InsuranceCategories: Wall Street Journal, insurance
Here’s a bit of good news for President Obama’s health law: it’s helping drive down the uninsured rate among young adults.
Data released today by the Centers for Disease Control and Prevention show that in the first quarter of 2011, the percentage of adults between ages 19 and 25 without health insurance fell 3.5 percentage points — to 30.4%. That translates to about an additional 1 million people that got coverage from the previous year.
It’s the third survey in recent weeks ..read more
-
Friday, August 19th, 2011 at 06:03 | Comments Off
CDC Says More Pregnant Women, Health-Care Workers Need Flu ShotCategories: Wall Street Journal
By Timothy W. Martin
More flu shots than ever will be produced for the upcoming influenza season, as public-health officials keep trying to spur more Americans — particularly health-care workers and pregnant women – to get vaccinated.
The Centers for Disease Control and Prevention said on a media teleconference today that it expects about 166 million flu shots to be produced this year, an increase from last season’s 157 million. Nearly half of children, 6 months to 17 years old, got flu ..read more
-
Saturday, July 30th, 2011 at 02:25 | Comments Off
Charred Shrink Wrap in Merck Vaccines: Read the FDA Inspection ReportsCategories: Wall Street Journal
When you make drugs or other medical products, unwanted contaminants can fall into the mix — say, beetle parts (in baby formula) or glass flakes (in anemia drugs).
The latest pharma world example of wow-that-really-shouldn’t-be-in-there comes from Merck. As the WSJ reports, the company says charred bits of plastic shrink wrap have been found in vials of vaccines made at a big plant in West Point, Pa.
Affected products include Gardasil, used against the human papillomavirus, as well as shots against shingles, ..read more
-
Tuesday, July 26th, 2011 at 01:23 | Comments Off
How Does Chickenpox Kill?Categories: Wall Street Journal
For the Health Blog, the major trauma of the chickenpox was breaking out in itchy blisters mere weeks before the senior prom. But in rare cases, chicken pox can actually kill people, and new research shows how vaccination has helped curb the number of annual deaths from the disease.
Writing online in the journal Pediatrics, researchers from the Centers for Disease Control and Prevention track the number of annual deaths with varicella — the scientific name for chickenpox — since a ..read more
-
Tuesday, July 19th, 2011 at 02:35 | Comments Off
The Flu Vaccine is On its WayCategories: Wall Street Journal
No, summer isn’t over yet. But preparations for the next flu season, which typically begins in October, have already started.
The FDA said today it’s approved the formulation for the 2011-12 vaccine. As we reported last month, the new vaccine looks a lot like it did last year — it will protect against the type of influenza A virus that caused the H1N1/swine flu pandemic, another type of influenza A virus (H3N2) and a type of influenza B virus. But you ..read more
-
Monday, June 13th, 2011 at 22:49 | Comments Off
A.M. Vitals: Pfizer Looks to Extend Viagra Patent to 2019Categories: Wall Street Journal
Patent Defense: Pfizer goes to court this week to try to extend its exclusive rights to sell Viagra — which has U.S. sales of $1 billion per year — until 2019, the WSJ reports. Pfizer’s basic patent on the drug, which was first developed to treat heart-related issues, expires next year, but the company is suing Teva Pharmaceuticals to prevent it from selling a generic version. Pfizer argues that a second patent covers the drug’s use specifically ..read more
-
Tuesday, April 26th, 2011 at 22:23 | Comments Off
A.M. Vitals: FDA to Regulate Electronic Cigarettes as Tobacco ProductsCategories: Wall Street Journal
E-Cigarette Rules: The FDA will regulate electronic cigarettes as tobacco products — like regular cigarettes — rather than as drug devices, such as nicotine gum, Dow Jones Newswires reports. The FDA preferred the latter designation, which would have required the agency to review e-cigarettes before they could be sold, but said yesterday it won’t seek further review of a January court decision that classified the devices as tobacco products.
Wider Use: The FDA expanded approval of Sanofi-Aventis’s meningitis ..read more
-
Monday, April 11th, 2011 at 22:34 | Comments Off
A.M. Vitals: Endo to Pay About $2.6 Billion for American Medical SystemsCategories: Wall Street Journal
Endo Buys: Endo Pharmaceutical Holdings will pay about $2.6 billion in cash for American Medical Systems, which makes minimally invasive products to treat men’s and women’s pelvic health conditions, the WSJ reports. The purchase price includes the assumption of $312 million in debt.
Time Out on Vaccine: Merck and Intercell AG said the independent data monitoring committee for a trial studying the companies’ experimental vaccine against the Staphylococcus aureus bacteria recommended study enrollment be halted, Bloomberg News reports. ..read more
